Related Experiment Video
Updated: Jan 15, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Risk of colorectal cancer after weight loss in the obese: a pooled cohort study
Shria Kumar1,2, Yalda Zarnegarnia3, Alla Sikorskii4
1Division of Digestive Health and Liver Diseases, Department of Medicine, Miller School of Medicine at the University of Miami, Miami, Florida, USA (Shria Kumar, David S. Goldberg).
Background:
Though the link between obesity and colorectal cancer (CRC) is convincing, the impact of weight loss after obesity on CRC risk is unknown.
Methods:
This pooled study from the Multiethnic Cohort, Nurses' Health Study and Health Professionals Follow-Up Study included adults aged 45-75, with 3+ available body mass index (BMI) measures. The primary analysis included persons of all weights, with exposure (BMI) subjected to group-based trajectory modeling. Time-to-incident CRC was evaluated using accelerated failure time models. A subanalysis evaluated the risk of CRC in persons with obesity who had weight loss, compared to persons with stable obesity.
Results:
A total of 193,046 persons were analyzed (median age 49 years, 66% female). Among persons with severe degrees of obesity who lost weight, there was a longer CRC-free duration in whites (acceleration factor [AF] 2.30, 95% confidence interval [CI] 1.23-4.29; P=0.01), persons of "Other" race (AF 2.54, 95%CI 2.45-2.63; P<0.001), Asian/Native Hawaiian/Other Pacific Islanders (AF 1.11, 95%CI 1.06-1.18; P<0.001), and Black/African Americans (AF 1.09, 95%CI 1.07-1.10; P<0.001). BMI was not associated with altered CRC risk in Hispanic/Latinos. Among 40,606 persons with obesity who had weight loss, higher degrees of weight loss were associated with a longer CRC-free duration. While weight loss of 5-10% had an AF of 1.14 (95%CI 1.04-1.24; P=0.01), the optimal degree of weight loss was 15-20%, AF 1.53 (95%CI 1.28-1.83; P<0.001).
Conclusions:
Weight loss after obesity is associated with a lower CRC risk in diverse populations. In persons with obesity, 15-20% weight loss appears to be optimal.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity
Drug Dosing: Obese Patients
Relative Risk
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Cancer Prevention
Some...

